Drupal.behaviors.print = function(context) {window.print();window.close();}>
Forsyth Wins Gates Foundation Grant for TB Biomarker Work on Quanterix's SiMoA System
February 10, 2012
Forsyth Wins Gates Foundation Grant for TB Biomarker Work on Quanterix's SiMoA System
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
Proteomics Researchers Well-Represented Among Gates Foundation TB Awardees
February 10, 2012 / ProteoMonitor
Quanterix's AccuPSA Test Predicts Five-Year Recurrence-Free Survival in Prostate Cancer Study
October 21, 2011 / ProteoMonitor
Quanterix and Sony DADC Ink Co-Development Deal for SiMoA Consumables
July 22, 2011 / ProteoMonitor
Shifting Focus From Dx Development, Quanterix Aims to Launch Commercial SiMoA Instrument in 2013
February 25, 2011 / ProteoMonitor
Proteomics Firms Net More than $8.75M in IRS Funds; Bulk of Awards Aimed at Diagnostics Work
November 5, 2010 / ProteoMonitor